Search

Your search keyword '"Respiratory syncytial virus -- Research"' showing total 10 results
Start Over Descriptor "Respiratory syncytial virus -- Research" Topic business
10 results on '"Respiratory syncytial virus -- Research"'

1. Considering the LIS in the molecular diagnostics context

Author

Schmidt, Megan

Subjects
Laboratories -- Management, Physicians -- Practice, Molecular diagnostic techniques -- Usage, Soft tissue injuries -- Care and treatment, Respiratory syncytial virus -- Research, Company business management, Business, Health care industry
Abstract

Laboratories have specific needs based on their size and testing types. Physician office laboratories, for example, typically perform fairly basic testing with straightforward setups. Larger laboratories, such as reference labs [...]

Published
2016

2. Alnylam, Cubist report progress on R&D effort

Subjects
Alnylam Pharmaceuticals Inc. -- Research, Cubist Pharmaceuticals Inc. -- Research, Pharmaceutical industry -- Research, Inhaled medication -- Usage, Inhaled medication -- Research, Respiratory syncytial virus -- Drug therapy, Respiratory syncytial virus -- Research, Respiratory tract infections -- Research, Respiratory tract infections -- Drug therapy, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals Inc. and Cubist Pharmaceuticals Inc. confirm that a midstage study of their experimental drug for a respiratory infection has met its major objective. The biopharmaceutical [...]

Published
2009

3. St. Jude study looks at risk factors for RSV

Subjects
Hospitals -- United States -- Research, Respiratory syncytial virus -- Research, Business, Pharmaceuticals and cosmetics industries, Retail industry, St. Jude Children's Research Hospital (Memphis, Tennessee) -- Research
Abstract

St. Jude's Research Hospital investigators have shown how to predict whether children are at risk for developing infection from respiratory syncytial virus. RSV is a common cause of pneumonia, causing [...]

Published
2008

4. Panacos gets SBIR grant for RSV project

Subjects
United States. National Institutes of Health -- Finance, Panacos Pharmaceuticals Inc. -- Finance, Pharmaceutical industry -- Finance, Respiratory syncytial virus -- Care and treatment, Respiratory syncytial virus -- Research, Company financing, Business, Pharmaceuticals and cosmetics industries
Abstract

Panacos Pharmaceuticals has received a $143,000 research grant from the US National Institutes of Health. The grant will be used for the development of respiratory syncytial virus drugs.

Published
2002

5. MedImmune expands RespiGam trials

Subjects
MedImmune L.L.C. -- Product development, Biotechnology industry -- Product development -- Testing, Respiratory syncytial virus -- Research, Business, Pharmaceuticals and cosmetics industries, RespiGam (Medication)
Published
1994

6. Shaman's human safety studies with Provir

Subjects
Shaman Pharmaceuticals Inc. -- Product development, Antiviral agents -- Testing, Respiratory syncytial virus -- Research, Pharmaceutical industry -- Product development, Business, Pharmaceuticals and cosmetics industries
Published
1993

7. Pivotal efficacy trial for Respivir

Subjects
MedImmune L.L.C. -- Product information, Pharmaceutical industry -- Product information, Respiratory syncytial virus -- Research, Business, Pharmaceuticals and cosmetics industries, Respivir (Medication) -- Research
Published
1993

8. Scotgen Ltd

Subjects
Scotgen Ltd. -- Joint ventures, SmithKline Beecham Corp. -- Joint ventures, Licensing agreements -- Contracts, Respiratory syncytial virus -- Research, Pharmaceutical industry -- Licensing agreements, Biotechnology industry, Business
Published
1991

10. Scotgen, SmithKline to work on syncytial virus

Subjects
Scotgen Ltd. -- Planning, SmithKline Beecham Corp. -- Planning, Pharmaceutical industry -- Research, Respiratory syncytial virus -- Research, Biotechnology industry, Business
Published
1991

Catalog

Books, media, physical & digital resources
See catalog results